RNA Therapeutics Market Size
Market Size in USD Mn
CAGR68.2%
| Study Period | 2025-2032 |
| Base Year of Estimation | 2024 |
| CAGR | 68.2% |
| Market Concentration | Medium |
| Major Players | Alphavax, Arcturus Therapeutics, Atyr Pharma, Gritstone Bio, HDT Bio and Among Others |
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
RNA Therapeutics Market Analysis
The RNA Therapeutics Market is estimated to be valued at USD 4.2 Mn in 2025 and is expected to reach USD 160.0 Mn by 2032, growing at a compound annual growth rate (CAGR) of 68.2% from 2025 to 2032.
The RNA therapeutics market is witnessing positive growth trends over the past few years. Factors such as increasing investment in RNA-based drug development, growing focuses on rare diseases and genetic disorders, rising prevalence of infectious diseases and cancer are expected to drive the demand for RNA therapeutics during the forecast period.